Unknown

Dataset Information

0

LKB1/STK11 inactivation leads to expansion of a prometastatic tumor subpopulation in melanoma.

ABSTRACT: Germline mutations in LKB1 (STK11) are associated with the Peutz-Jeghers syndrome (PJS), which includes aberrant mucocutaneous pigmentation, and somatic LKB1 mutations occur in 10% of cutaneous melanoma. By somatically inactivating Lkb1 with K-Ras activation (±p53 loss) in murine melanocytes, we observed variably pigmented and highly metastatic melanoma with 100% penetrance. LKB1 deficiency resulted in increased phosphorylation of the SRC family kinase (SFK) YES, increased expression of WNT target genes, and expansion of a CD24(+) cell population, which showed increased metastatic behavior in vitro and in vivo relative to isogenic CD24(-) cells. These results suggest that LKB1 inactivation in the context of RAS activation facilitates metastasis by inducing an SFK-dependent expansion of a prometastatic, CD24(+) tumor subpopulation.

SUBMITTER: Liu W 

PROVIDER: S-EPMC3660964 | biostudies-literature | 2012 Jun

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Germline mutations in LKB1 (STK11) are associated with the Peutz-Jeghers syndrome (PJS), which includes aberrant mucocutaneous pigmentation, and somatic LKB1 mutations occur in 10% of cutaneous melanoma. By somatically inactivating Lkb1 with K-Ras activation (±p53 loss) in murine melanocytes, we observed variably pigmented and highly metastatic melanoma with 100% penetrance. LKB1 deficiency resulted in increased phosphorylation of the SRC family kinase (SFK) YES, increased expression of WNT targ  ...[more]

Similar Datasets

Transcriptomics LKB1/STK11 Inactivation Leads to Expansion of Pro-Metastatic Tumor Sub-Population in Melanoma
2012-06-24 | E-GEOD-34866 | biostudies-arrayexpress
Transcriptomics LKB1/STK11 Inactivation Leads to Expansion of Pro-Metastatic Tumor Sub-Population in Melanoma
2012-06-25 | GSE34866 | GEO
Unknown STK11 (LKB1) missense somatic mutant isoforms promote tumor growth, motility and inflammation.
| S-EPMC7347935 | biostudies-literature
Unknown Pten deletion leads to the expansion of a prostatic stem/progenitor cell subpopulation and tumor initiation.
| S-EPMC1345717 | biostudies-literature
Unknown LKB1/<i>STK11</i> Is a Tumor Suppressor in the Progression of Myeloproliferative Neoplasms.
| S-EPMC8178182 | biostudies-literature
Unknown Lkb1/Stk11 regulation of mTOR signaling controls the transition of chondrocyte fates and suppresses skeletal tumor formation.
| S-EPMC3845115 | biostudies-literature
Transcriptomics LKB1/STK11 Is a Tumor Suppressor in the Progression of Myeloproliferative Neoplasms
2022-08-01 | GSE210253 | GEO
Unknown LKB1 inactivation leads to centromere defects and genome instability via p53-dependent upregulation of survivin.
| S-EPMC7425461 | biostudies-literature
Unknown A novel mutation of STK11/LKB1 gene leads to the loss of cell growth inhibition in head and neck squamous cell carcinoma.
| S-EPMC1459486 | biostudies-literature
Unknown Somatic mutations in the STK11/LKB1 gene are uncommon in rare gynecological tumor types associated with Peutz-Jegher's syndrome.
| S-EPMC1868646 | biostudies-literature